New call-to-action
New call-to-action
New call-to-action

New Evidence Supports Benefits of Hippotherapy

A new study further supports the benefits of hippotherapy with regards to behavioral tasks and cognitive development.

new-evidence-supports-benefits-of-hippotherapy.jpgA new study highlighted in Medical News Today further supports the benefits of hippotherapy with regards to behavioral tasks and cognitive development. Hippotherapy is the use of horseback riding as a therapeutic or rehabilitative treatment.

The full article is available here on the Frontiers In Public Health website. Interestingly, the results indicate that the benefit may be linked to the horse's vibration/gait, which can vary by horse. So some horses may provide better benefit than others

This study was conducted in typical children age 10-12. However, hippotherapy is commonly recommended for children with PWS and was described in the blog post PWS Early Interventions: 5 Therapies for Prader-Willi SyndromeAttendees at the FPWR conference in 2014 may remember that there was a presentation on hippotherapy as a treatment approach for physical, occupational, speech, and language therapy. (For more sessions on PWS therapies, check out the 2017 FPWR conference.) 

Within the Global PWS Registry, 38% of participants report having tried hippotherapy. Of those who have tried it, 70% report noticeable, meaningful benefit for their loved one in behavior, mental health, and / or coping. 

For more information on hippotherapy, visit the American Hippotherapy Association website

PWS First Steps Ebook CTA Blog

Topics: Research

Jessica Bohonowych


Jessica Bohonowych is a graduate of Duke University, and holds a PhD in Pharmacology and Toxicology at the University of California, Davis. Incorporating her research background, knowledge of pharmacology and drug development, and teaching experience, Jessica works with Theresa Strong in managing FPWR’s grant portfolio, communicating research results and breakthroughs to our community, aiding in special projects such as the Clinical Trials Initiative and Molecular Resource Center, and is heading the development of the Global PWS Registry.